Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology...
Telemedicine
CharmHealth Launches 2023 Innovation Challenge to Revolutionize Healthcare
Now Accepting Proposals for Disruptive Ideas That Address the Most Pressing Issues Across the Healthcare LandscapePLEASANTON, Calif.--(BUSINESS WIRE)--#AI--CharmHealth, a leading...
AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities
CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...
AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities
CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...
Modern Mobility Aids, Inc. Q3 2023 Update to Shareholders
BRAMPTON, ON / ACCESSWIRE / July 10, 2023 / Modern Mobility Aids Inc, (OTC:MDRM) is pleased to update our shareholders...
Earth Science Tech, Inc Initiates Up-Listing Process to the OTCQB Exchange with the OTC Markets Group, Inc.
Miami, FL, July 06, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently...
LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements
Proprietary platform enhancements elevate LifeMD's GLP-1 weight management program with best-in-class clinician-directed care and personalized guidance Figure 1 Enhanced LifeMD...
Earth Science Tech, Inc Shares a Letter from the CEO on Recently Filed March 31, 2023, YE Report
“You don’t have to be great to start, but you do have to start to be great!” Miami, FL, June...
Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants
Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant (NCI R01) awarded to UTHSC...
Mangoceuticals, Inc. Announces Upcoming Launch of its Sildenafil Based Mango Flavored Rapid Dissolve ED Product
Dallas, Texas, June 21, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
LifeMD Appoints William J. Febbo to its Board of Directors
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today...
Mangoceuticals, Inc. Signs Sponsorship Agreement with GaS Digital Network to Promote Mango Across Multiple Hardcore Comedy Podcasts
Mangoceuticals continues to increase its marketing of Mango & corporate visibility, jointing many well-known podcasts in the epicenter of uncensored...
Augmedix Extends Term Loan Facility and Finalizes Terms for Equity Line of Credit
Balance Sheet Initiatives Bolster Financial Strength as Company Scales Business Towards Cash Flow Break-EvenSAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE)...
Mangoceuticals Signs Deal with BarStool Sports to Market Mango on Popular “Only Stans” Podcast
Dallas, Texas, June 08, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical...
Augmedix Announces Participation in Upcoming Investor Conferences
SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation...
Science 37 Wins 2023 MedTech Breakthrough Award for “Best Overall Clinical Trial Platform”
Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovationRESEARCH TRIANGLE PARK, N.C., May...
Augmedix Delivers Continued Sales Momentum; Reports First Quarter 2023 Financial Results
SAN FRANCISCO, May 12, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical...
Veru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS
Reached agreement with FDA on confirmatory Phase 3 clinical trial design in 408 subjects with primary endpoint of all-cause mortality...
Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital
MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...